PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Novel anti-microbial peptide SR-0379 accelerates wound healing via the PI3 kinase/Akt/mTOR pathway.

Rat / Wound

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 24675668 ↗2014Reported benefit

Novel anti-microbial peptide SR-0379 accelerates wound healing via the PI3 kinase/Akt/mTOR pathway.

RatWoundCrl:CD(SD)Malen = 4 to 5 rats per group in the disc implantation experiments;…Topical to the wound; subcutaneous implantation for the disc model0.2 mg/ml in 50 microlitres for the diabetic flap model; 1…From the time of wounding, with bacteria applied on days 0 to 3 in the infected…

Model: Full-thickness skin defect with flap in streptozotocin-induced diabetic rats; full-thickness wound inoculated with Staphylococcus aureus in cyclophosphamide-treated rats; incised wound and paper disc implantation models

SR-0379 significantly accelerated wound closure compared with fibroblast growth factor 2 in both the diabetic flap model and the Staphylococcus aureus-infected full-thickness model, with enhanced angiogenesis, granulation tissue formation and proliferation of endothelial cells and fibroblasts along…

Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.